Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)Release Date:Research Hospital All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets AsiaEducation Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Improving Real-World Evidence & Data Generation Skills in Latin AmericaRelease Date:Education Support for the Professions All Optimizing Venous Thromboembolism Management in Latin AmericaRelease Date:Quality Improvement Internal Medicine All Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)Release Date:Research Inflammation & Immunology All Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited SettingsRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Increase HCP knowledge of Gene Therapy managementRelease Date:Education Rare Disease China Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)Release Date:Research Vaccines All Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology All Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except ChinaRelease Date:Education Oncology All Acute Lymphoblastic Leukemia Peer-to-Peer Education & SupportRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast CancerRelease Date:Education Oncology USA Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patientsRelease Date:Quality Improvement Inflammation & Immunology All ADVANCE: Global Awards for Advancing Chronic Pain ResearchRelease Date:Research Internal Medicine All Enhancing the Understanding of Health Maintenance in the Management of IBDRelease Date:Education Inflammation & Immunology USA Outpatient Management of COVID-19Release Date:Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan Emerging Therapies in Alopecia Areata for Dermatologists - United StatesRelease Date:Education Inflammation & Immunology USA Virtual Programs for Rheumatology EducationRelease Date:Education Inflammation & Immunology USA 2021/2022 Global NASH ASPIRERelease Date:Research Internal Medicine All Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)Release Date:Education Inflammation & Immunology All 2021/2022 Global Obesity ASPIRERelease Date:Research Internal Medicine All Geriatric Anorexia – Educational Needs AssessmentRelease Date:Education Internal Medicine USA Advances in Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA 2021/2022 Global Cachexia ASPIRERelease Date:Research Internal Medicine All Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for AllergistsRelease Date:Partner: American College of Allergy, Asthma & Immunology (ACAAI)Education Inflammation & Immunology USA Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care PhysiciansRelease Date:Education Inflammation & Immunology USA Pediatric Growth Hormone Deficiency EducationRelease Date:Education Rare Disease USA 2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiencesRelease Date:Research Inflammation & Immunology Italy Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)Release Date:Education Rare Disease All Cardiac Amyloidosis Mentor mATTch pRogramEducation Rare Disease USA Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New ZealandRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing RegionsRelease Date:Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Optimizing Telehealth Use in CanadaRelease Date:Quality Improvement Internal Medicine Canada Improving ATTR Amyloidosis Management in SpainRelease Date:Quality Improvement Rare Disease Spain Equity in Access to Rare Disease Clinical TrialsRelease Date:Quality Improvement Rare Disease USA 2022 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2022 IBD Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Management of EndometriosisEducation Internal Medicine USA Establishment of an Appropriate Network of Medical Care and Education for Axial SpondyloarthritisRelease Date:Partner: The Japan Spondyloarthritis SocietyQuality Improvement Inflammation & Immunology Japan 2022 Global Hemophilia ASPIRERelease Date:Research Rare Disease All 2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin AmericaRelease Date:Research Rare Disease All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA 2022 Fellowship for Inflammatory Dermatological DiseasesRelease Date:Fellowship Inflammation & Immunology USA 2022 Rheumatology FellowshipRelease Date:Fellowship Inflammation & Immunology USA